Audeo Oncology Inc

Audeo Oncology, Inc. is a late stage biopharmaceutical company primarily focused on utilizing Hyaluronic Acid Chemotransport Technology, or HyACT, to target cancer drugs preferentially to tumor cells to enhance drug activity.